carbamates has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, TS | 1 |
| Avraham, HK | 1 |
| Seng, S | 1 |
| Tachado, SD | 1 |
| Koziel, H | 1 |
| Makriyannis, A | 1 |
| Avraham, S | 1 |
| Kost, RG | 1 |
| Hurley, A | 1 |
| Zhang, L | 1 |
| Vesanen, M | 1 |
| Talal, A | 1 |
| Furlan, S | 1 |
| Caldwell, P | 1 |
| Johnson, J | 1 |
| Smiley, L | 1 |
| Ho, D | 1 |
| Markowitz, M | 1 |
1 trial available for carbamates and Acquired-Immune Deficiency Syndrome Dementia Complex
| Article | Year |
|---|---|
Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anti-HIV Agents; Carbamates; CD4 L | 2001 |
1 other study available for carbamates and Acquired-Immune Deficiency Syndrome Dementia Complex
| Article | Year |
|---|---|
Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells.
Topics: AIDS Dementia Complex; Amidohydrolases; Anti-HIV Agents; Arachidonic Acids; Benzamides; Blood-Brain | 2008 |